Overall prescribing trends The study found that 1,162,662 patients were prescribed a GLP-1 RA between January 2018 and June 2024, with 4,815,135 total prescriptions during this period
The partners are now studying the GLP-1/glucagon receptor dual agonist in the Phase III SYNCHRONIZE clinical development program, with three studies launched in May 2023
We cannot discuss GLP-1 receptor agonists without discussing weight loss, because that is the context in which most of your patients, and frankly most of the popular press, know these medications
Important CGMiner Figures Over 14 years of ongoing development No developer commissions Support for over 50 ASIC models A global user base of more than 100,000 miners Ready to Begin Mining
The peptide plays a fundamental role in preserving the lining of the GI tract
Planning meals in advance prevents the impulse eating of trigger foods that worsens symptoms